Medicine
Trihexyphenidyl 2 mg/5 mL oral solution
Trihexyphenidyl 2 mg/5 mL oral solution is a generic prescription medicine for oral use, made by 2 labelers, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians.
Availability
Export supply from India to licensed buyers
Typical lead time
On request
Counted from payment and complete documents
Shipping
Ambient
Store at 20° to 25°C (68° to 77°F).
Key facts
- Active ingredient (INN)
- Trihexyphenidyl
- Brand
- Sold under the generic name
- Strength
- 2 mg/5 mL
- Dosage form
- Oral solution
- Route
- Oral
- Packs
- 473 mL
- Manufacturers
- Chartwell RXPAI Pharma
- Origin register
- US FDA, United States
- Storage
- Store at 20° to 25°C (68° to 77°F).
- Cold chain
- Not required on record
- Prescription status
- Prescription only
- Controlled substance
- Not recorded as controlled
- ATC code
- N04AA01 Trihexyphenidyl
- HS code (indicative)
- 3004.90Indicative only. Your customs broker confirms the final tariff code.
- Marketing category
- marketed
- Marketed since
- 15 May 1997
- Identifiers
- RxCUI 905273DailyMed set ID 9036c9f0-6d2d-4d0f-a20e-e36f9be228f7, e8e2ac3b-80dc-4449-9365-2586d6d57e10NDC 0121-0658, 62135-065Application ANDA040177, ANDA040251
Record updated 12 November 2026
Documents available
Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.
No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.
Packs
Packs from every labeler of this generic presentation.
| Pack | Code | Labeler | Marketed since |
|---|---|---|---|
| 473 mL in 1 bottle | 62135-065-47 | Chartwell RX | 1 July 2026 |
| 473 mL in 1 bottle | 0121-0658-16 | PAI Pharma | 15 May 1997 |
Status by register
Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.
| Register | Status | Source |
|---|---|---|
| US FDA | Listed, marketed | Source record for this pageChecked 12 November 2026 |
| US FDA | First approved 13 May 1949 | Drugs@FDA |
| EU (EMA) | Not recorded | — |
| India (CDSCO) | Not yet confirmed against CDSCO approval lists | — |
| United States | Registered | US FDA (NDC directory, openFDA)Checked 12 November 2026 |
Import route
Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.
Import guides are available for 25 countries. Pick one to see its route summary.
BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides
Other strengths and forms of Trihexyphenidyl
Clinical summary
Trihexyphenidyl is a prescription medicine indicated as an adjunct in the treatment of all forms of parkinsonism (postencephalitic, arteriosclerotic, and idiopathic). It is available as tablets, oral solution and syrup. MedsAcross supplies Trihexyphenidyl for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.
Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review
Read about TrihexyphenidylFor healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.
Data sources
- DailyMed label record · Checked 12 November 2026
- Trihexyphenidyl Hydrochloride prescribing information (Chartwell RX) · U.S. National Library of Medicine, DailyMed
Need Trihexyphenidyl 2 mg/5 mL oral solution for your hospital or patient?
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.